NEW YORK (GenomeWeb News) – Phalanx Biotech Group has licensed Rosetta Biosoftware's Resolver system for use in its high-throughput gene expression and miRNA profiling services.

Rosetta said that its software system will enable the Taiwan-based microarray and genomics services firm to meet data management and analysis requirements associated with high sample volumes and will facilitate collaboration and results sharing between Phalanx and its customers.

Financial terms of the license were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.